INNATE PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.63 EUR | -0.19% |
|
+2.94% | +0.38% |
| May. 24 | Innate Pharma: five abstracts selected for ASCO | CF |
| May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INNATE PHARMA | Other Biotechnology & Medical Research | -0.19% | +2.94% | +0.38% | -5.40% | -56.53% | 231M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IPH Stock
- Charts Innate Pharma
- Comparison Chart
